View Resource
Originally published on The Lancet
David Osrin and Tim Colbourn (November, 2016) uphold a recommendation to restrict use of chlorhexidine to “infants born at home in environments with high neonatal mortality rates” and assert that “Cochrane reviews, a meta-analysis, and these two new trials have not supported an effect after hospital births”. We do not think it is clear how one could come to such a conclusion from the evidence in the cited papers.